Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers-Reference-Cited by-同舟云学术

Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers

Published:2017-12 Issue:12 Volume:27 Page:1511-1522
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Lebeault Maylis¹,Pinson Stéphane²³,Guillaud-Bataille Marine³⁴,Gimenez-Roqueplo Anne-Paule³⁵,Carrie Alain³⁶,Barbu Véronique³⁷,Pigny Pascal³⁸,Bezieau Stéphane³⁹,Rey Jean-Marc³¹⁰,Delvincourt Chantal³¹¹,Giraud Sophie²³,Veyrat-Durebex Charlotte³¹²¹³,Saulnier Patrick¹⁴,Bouzamondo Nathalie³¹³,Chabbert Marie¹²,Blin Julien¹⁵,Mohamed Amira³¹⁶,Romanet Pauline³¹⁶,Borson-Chazot Francoise³¹⁷,Rohmer Vincent¹³,Barlier Anne³¹⁶,Mirebeau-Prunier Delphine³¹²¹³

Affiliation:

1. Service d'Endocrinologie, CHU Angers, Angers, France.

2. Laboratoire de Génétique Moléculaire, CHU Lyon, Lyon France.

3. Réseau TenGen, France.

4. Département de Biologie et Pathologie Médicale, Gustave Roussy, Université de Paris-Saclay, Villejuif, France.

5. Service de Génétique, Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.

6. Centre de Génétique Moléculaire Chromosomique, Assistance Publique Hôpitaux de Paris, Paris, France.

7. Laboratoire Commun de Biologie et Génétique Moléculaires, HUEP, SAT, AP-HP Paris, France.

8. Laboratoire de Biochimie et Oncologie Moléculaire, CHU Lille, Lille, France.

9. Laboratoire de Génétique Moléculaire, CHU Nantes, Nantes, France.

10. Laboratoire de Biopathologie Cellulaire et Tissulaire des Tumeurs, CHU Montpellier, Montpellier, France.

11. Laboratoire de Biologie Oncologique, CHU Reims, Reims, France.

12. UMR CNRS 6015-INSERMU1083, Laboratoire MITOVASC, Université d'Angers, Angers, France.

13. Département de Biochimie et Génétique, CHU Angers, Angers, France.

14. Cellule de Méthodologie et Biostatistiques, Délégation à la Recherche Clinique et l'Innovation-DRCI, CHU Angers, Angers, France.

15. Institut National du Cancer—INCa, Paris, France.

16. Aix Marseille Univ, CNRS, CRN2M, UMR 7286, and APHM La Conception Hospital, Molecular Biology Laboratory, Marseille, France.

17. Hospices Civils de Lyon, Pôle IMER; Université Claude Bernard Lyon 1, HESPER EA 7425 Lyon, France.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2016.0399

Reference44 articles.

1. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma

2. Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association

3. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10

4. RET Cys634Arg mutation confers a more aggressive multiple endocrine neoplasia type 2A phenotype than Cys634Tyr mutation

5. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular testing raises thyroid nodule fine needle aspiration diagnostic value;Endocrine Connections;2023-06-13

2. RET Proto-Oncogene Variants in Patients with Medullary Thyroid Carcinoma from the Mediterranean Basin: A Brief Report;Life;2023-06-06

3. Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930–2021: A Nationwide Population-Based Retrospective Study;Cancers;2023-04-02

4. A Case of 123I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developing Mutation in the RET Gene;Journal of Clinical Medicine;2022-08-08

5. Medullary Thyroid Carcinoma and Associated Endocrinopathies in Slovenia from 1995 to 2021;Life;2022-07-21